[Global adherence project to disease-modifying therapies in patients with relapsing multiple sclerosis: 2-year interim results].

@article{Arroyo2010GlobalAP,
  title={[Global adherence project to disease-modifying therapies in patients with relapsing multiple sclerosis: 2-year interim results].},
  author={Elsa Arroyo and Cai Grau and Cristina Ramo and Joaqu{\'i}n Parra and O. S{\'a}nchez-Soli{\~n}o},
  journal={Neurologia},
  year={2010},
  volume={25 7},
  pages={435-42}
}
BACKGROUND In this article we report adherence data from the first 2 years in a subset of patients from the Global Adherence Project (GAP; n=2,648) in Spain. METHODS A questionnaire assessing adherence to Disease-modifying therapies (DMTs), was distributed annually to patients and their treating neurologists. Non-adherence was defined as missing a DMT injection or changing a dose in the four weeks prior to completing the survey. Patients signed informed consent and Ethics Committees approved… CONTINUE READING